Advertisement

Imaging of Brain Perfusion

  • John O. PriorEmail author
Chapter

Abstract

Brain perfusion by SPECT or PET is a well-established and reliable method to measure regional cerebral blood flow (rCBF). The normal adult brain perfusion is symmetrical with higher tracer distribution in the temporal, parietal and occipital (visual) cortices, basal ganglia, thalami and cingulate gyrus than in the white matter and interhemispheric fissure [1]. Depending whether the eyes are open or closed, an increase of ca. 30 % more in the occipital visual cortex can be observed [1]. Motor and sensory stimuli can have asymmetrical effects. In the newborn, perfusion is slightly lowered in the frontal and temporoparietal regions and reaches an “adult” pattern within the first 2 years of life [1]. As the same SPECT pattern may be encountered in several pathologies (Table 1), detailed knowledge of the patient’s symptoms and the functional area of the brain likely to be involved is important.

Keywords

Traumatic Brain Injury Attention Deficit Hyperactivity Disorder Chronic Fatigue Syndrome Brain Perfusion Chronic Traumatic Encephalopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Camargo EE (2001) Brain SPECT in neurology and psychiatry. J Nucl Med 42(4):611–623PubMedGoogle Scholar
  2. 2.
    Heiss W-D (2011) The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. Cerebrovasc Dis 32(4):307–320CrossRefPubMedGoogle Scholar
  3. 3.
    Abraham T, Feng J (2011) Evolution of brain imaging instrumentation. Semin Nucl Med 41(3):202–219CrossRefPubMedGoogle Scholar
  4. 4.
    Herholz K (2011) Perfusion SPECT and FDG-PET. Int Psychogeriatr 23(S2):S25–S31CrossRefPubMedGoogle Scholar
  5. 5.
    O’Brien JT, Firbank MJ, Davison C, Barnett N, Bamford C, Donaldson C, Olsen K, Herholz K, Williams D, Lloyd J (2014) 18F-FDG PET and perfusion SPECT in the diagnosis of alzheimer and lewy body dementias. J Nucl Med 55(12):1959–1965CrossRefPubMedGoogle Scholar
  6. 6.
    Bhogal P, Mahoney C, Graeme-Baker S, Roy A, Shah S, Fraioli F, Cowley P, Jäger HR (2013) The common dementias: a pictorial review. Eur Radiol 23(12):3405–3417CrossRefPubMedGoogle Scholar
  7. 7.
    Henderson TA (2012) The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging. CNS Spectr 17(04):176–206CrossRefPubMedGoogle Scholar
  8. 8.
    Rostami E, Engquist H, Enblad P (2014) Imaging of cerebral blood flow in patients with severe traumatic brain injury in the neurointensive care. Front Neurol 5:4–114Google Scholar
  9. 9.
    Catafau AM (2001) Brain SPECT in clinical practice. Part I: perfusion. J Nucl Med 42(2):259–271PubMedGoogle Scholar
  10. 10.
    Farid K, Petras S, Ducasse V, Chokron S, Helft G, Blacher J, Caillat-Vigneron N (2012) Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairment. Nucl Med Commun 33(6):571–580CrossRefPubMedGoogle Scholar
  11. 11.
    O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST (2003) Vascular cognitive impairment. Lancet Neurol 2(2):89–98CrossRefPubMedGoogle Scholar
  12. 12.
    Oku N, Kashiwagi T, Hatazawa J (2010) Nuclear neuroimaging in acute and subacute ischemic stroke. Ann Nucl Med 24(9):629–638CrossRefPubMedGoogle Scholar
  13. 13.
    Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK (2009) Quantitative hemodynamic studies in moyamoya disease. Neurosurg Focus 26(4):E5CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kuhn FP, Warnock G, Schweingruber T, Sommerauer M, Buck A, Khan N (2015) Quantitative H2[15O]-PET in pediatric moyamoya disease: evaluating perfusion before and after cerebral revascularization. J Stroke Cerebrovasc Dis 24(5):965–971CrossRefPubMedGoogle Scholar
  15. 15.
    Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W (2008) Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 38(4):227–239CrossRefPubMedGoogle Scholar
  16. 16.
    Patil S, Biassoni L, Borgwardt L (2007) Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med 37(5):357–381CrossRefPubMedGoogle Scholar
  17. 17.
    la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P (2009) PET and SPECT in epilepsy: a critical review. Epilepsy Behav 15(1):50–55CrossRefPubMedGoogle Scholar
  18. 18.
    Siclari F, Prior JO, Rossetti AO (2013) Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res 105(3):356–361CrossRefPubMedGoogle Scholar
  19. 19.
    Masdeu J, Arbizu J (2008) Brain single photon emission computed tomography: technological aspects and clinical applications. Semin Neurol 28(04):423–434CrossRefPubMedGoogle Scholar
  20. 20.
    Santra A, Kumar R (2014) Brain perfusion single photon emission computed tomography in major psychiatric disorders: from basics to clinical practice. Indian J Nucl Med 29(4):210–220CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Cho SC, Hwang JW, Kim BN, Lee HY, Kim HW, Lee JS, Shin MS, Lee DS (2007) The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders. J Psychiatr Res 41(6):459–465CrossRefPubMedGoogle Scholar
  22. 22.
    Kanahara N, Shimizu E, Sekine Y, Uchida Y, Shibuya T, Yamanaka H, Hashimoto T, Asaka T, Sasaki T, Miyatake R, Ohkami T, Fukami G, Fujisaki M, Watanabe H, Shirayama Y, Hayashi H, Hashimoto K, Asano M, Iyo M (2009) Does hypofrontality expand to global brain area in progression of schizophrenia?: a cross-sectional study between first-episode and chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33(3):410–415CrossRefPubMedGoogle Scholar
  23. 23.
    Kucuk NO, Kilic EO, Ibis E, Aysev A, Gencoglu EA, Aras G, Soylu A, Erbay G (2000) Brain SPECT findings in long-term inhalant abuse. Nucl Med Commun 21(8):769–773CrossRefPubMedGoogle Scholar
  24. 24.
    Devous MD Sr (1992) Comparison of SPECT applications in neurology and psychiatry. J Clin Psychiatry 53(Suppl):13–19PubMedGoogle Scholar
  25. 25.
    Kapucu ÖL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, Darcourt J, Tatsch K, Van Laere KJ (2009) EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging 36(12):2093–2102CrossRefPubMedGoogle Scholar
  26. 26.
    Juni JE, Waxman AD, Devous MD, Tikofsky RS, Ichise M, Van Heertum RL, Carretta RF, Chen CC (2009) Procedure guideline for brain perfusion SPECT using 99mTc radiopharmaceuticals 3.0. J Nucl Med Technol 37(3):191–195CrossRefPubMedGoogle Scholar
  27. 27.
    Friberg L, Andersen AR, Lassen NA, Holm S, Dam M (1994) Retention of 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 14(Suppl 1):S19–S27PubMedGoogle Scholar
  28. 28.
    Lassen NA, Andersen AR, Friberg L, Paulson OB (1988) The retention of [99mTc]-d, l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 8(6):S13–S22CrossRefPubMedGoogle Scholar
  29. 29.
    Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H (1997) SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38(4):587–592PubMedGoogle Scholar
  30. 30.
    Lassmann M, Treves ST, Group ESPDHW (2014) Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging 41(5):1036–1041CrossRefPubMedGoogle Scholar
  31. 31.
    Maeda Y, Kudomi N, Sasakawa Y, Monden T, Kato K, Yamamoto Y, Kawai N, Nishiyama Y (2015) Applicability of emission-based attenuation map for rapid CBF, OEF, and CMRO2 measurements using gaseous 15O-labeled compounds. EJNMMI Phys 2(1):12CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Nuclear Medicine and Molecular ImagingLausanne University HospitalLausanneSwitzerland

Personalised recommendations